Current evidence from large-scale studies is reassuring, showing no increased breast cancer risk associated with GLP-1 use
WADA category S5 is made up predominantly of diurectics including furosemide, hydrochlorothiazide, spironolactone, and acetazolamide
What clinical evidence supports GLP-1 medications for weight loss
While traditionally recommended for short-term use, some patients may require longer-term supervised use as part of a bowel management plan
These Could Be Signs of a More Serious Problem That Requires Prompt Treatment
In comparison, someone tapering off completely might use even smaller, non standard amounts, such as 0.125 mg weekly, which is not part of approved dosing guidelines and would require manual adjustment